D. Leveque et al., BILIARY ELIMINATION AND PHARMACOKINETICS OF VINORELBINE IN MICROPIGS, Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 487-490
The biliary elimination and pharmacokinetics of vinorelbine (NVB) were
investigated in five conscious micropigs provided with a double-termi
nal choledocal fistula allowing the collection and reinstillation of b
ile. After the i. v. administration of NVB (0.5 mg/kg), serum and bile
samples were collected over a 48-h period. The concentrations of NVB
were measured by high-performance liquid chromatography. The serum con
centrations decreased rapidly from a maximal value of 208.6 ng/ml (SD,
111.7 ng/ml). The mean half-life was 10.9 h (SD, 8.6 h) and the mean
AUC0-48 h was 292.8 ng ml-1 h (SD, 79.4 ng ml-1 h). The bile concentra
tions were high, amounting to 16.0 mug/ml (range, 5.4-27.7 mug/ml). Th
e 0- to 48-h biliary excretion of unchanged NVB accounted for 25.8% (S
D, 5.7%) of the injected dose, with 21.5% (SD, 4.0%) being eliminated
during the 0- to 8-h period. Desacetyl-NVB was found in an inconstant
manner and in very low amounts in bile samples. In addition, no glucur
onide of NVB could be detected. Thus, in the micropig, biliary excreti
on represents an important route of elimination for NVB.